CFIHX
Price
$69.91
Change
+$0.34 (+0.49%)
Updated
Jan 17 closing price
Net Assets
106.93B
NRIFX
Price
$21.40
Change
+$0.02 (+0.09%)
Updated
Jan 17 closing price
Net Assets
1.11B
Ad is loading...

CFIHX vs NRIFX

Header iconCFIHX vs NRIFX Comparison
Open Charts CFIHX vs NRIFXBanner chart's image
American Funds Capital Income Bldr F3
Price$69.91
Change+$0.34 (+0.49%)
VolumeN/A
Net Assets106.93B
Nuveen Real Asset Income R6
Price$21.40
Change+$0.02 (+0.09%)
VolumeN/A
Net Assets1.11B
CFIHX vs NRIFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CFIHX vs. NRIFX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CFIHX is a Hold and NRIFX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CFIHX has more cash in the bank: 107B vs. NRIFX (1.11B). NRIFX pays higher dividends than CFIHX: NRIFX (5.11) vs CFIHX (3.59). CFIHX was incepted earlier than NRIFX: CFIHX (8 years) vs NRIFX (9 years). CFIHX is a more actively managed with annual turnover of: 106.00 vs. NRIFX (60.00). CFIHX (1000000) and NRIFX (1000000) have matching initial minimum investment requirements. CFIHX annual gain was more profitable for investors over the last year : 11.08 vs. NRIFX (9.91). CFIHX return over 5 years is better than : 24.07 vs. NRIFX (10.10).
CFIHXNRIFXCFIHX / NRIFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years9 years-
Gain YTD1.4360.517278%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets107B1.11B9,683%
Annual Yield % from dividends3.595.1170%
Returns for 1 year11.089.91112%
Returns for 3 years8.234.25194%
Returns for 5 years24.0710.10238%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVRO4.570.07
+1.56%
NEVRO Corp
RVLV30.020.42
+1.42%
Revolve Group
JLL261.682.17
+0.84%
Jones Lang LaSalle
BDRX4.28-0.06
-1.38%
Biodexa Pharmaceuticals plc
RSSS3.65-0.21
-5.44%
Research Solutions